Abstract
To the Editor: Pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC) are rare papulosquamous disorders.1 While PLEVA/PLC can relapse and remit, persistent cases may warrant therapy.1 Methotrexate (MTX) has been investigated previously in 13 pediatric PLEVA/PLC patients (100% response rate), 6 PLEVA patients (100% complete resolution), and 4 PLEVA patients (0% response rate).1-4 We evaluated MTX for PLEVA/PLC in 33 patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
